Estrogen-replacement therapy after breast cancer. Risks versus benefits.
about
Estrogen replacement therapy after treatment for localized breast carcinoma. Patient responses and opinions.Effects of receptor tyrosine kinase inhibitor A47 on estrogen and growth factor-dependent breast cancer cell proliferation and apoptosis in vitro.Estrogen replacement therapy in breast cancer survivors.Management of Menopausal Symptoms in Breast Cancer Patients
P2860
Estrogen-replacement therapy after breast cancer. Risks versus benefits.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Estrogen-replacement therapy after breast cancer. Risks versus benefits.
@en
type
label
Estrogen-replacement therapy after breast cancer. Risks versus benefits.
@en
prefLabel
Estrogen-replacement therapy after breast cancer. Risks versus benefits.
@en
P2860
P1433
P1476
Estrogen-replacement therapy after breast cancer. Risks versus benefits.
@en
P2093
Marchant DJ
P2860
P304
P356
10.1002/1097-0142(19930315)71:6+<2169::AID-CNCR2820711608>3.0.CO;2-B
P407
P433
P577
1993-03-01T00:00:00Z